Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 657

1.

Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.

Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, Funahashi T, Matsuzawa Y, Shimomura I, Dekker JM.

Diabetes Care. 2006 Nov;29(11):2498-503.

PMID:
17065691
3.

The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men.

Wei M, Gibbons LW, Mitchell TL, Kampert JB, Lee CD, Blair SN.

Ann Intern Med. 1999 Jan 19;130(2):89-96. Erratum in: Ann Intern Med 1999 Sep 7;131(5):394.

PMID:
10068380
4.

Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study.

van Dam RM, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ; Hoorn study..

Diabetologia. 2004 Dec;47(12):2152-9. Epub 2004 Dec 11.

PMID:
15662556
5.

Leptin and incident type 2 diabetes: risk or protection?

Schmidt MI, Duncan BB, Vigo A, Pankow JS, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G; ARIC Investigators..

Diabetologia. 2006 Sep;49(9):2086-96. Epub 2006 Jul 19.

PMID:
16850292
6.

Adipokines and risk of type 2 diabetes in older men.

Wannamethee SG, Lowe GD, Rumley A, Cherry L, Whincup PH, Sattar N.

Diabetes Care. 2007 May;30(5):1200-5. Epub 2007 Feb 23.

PMID:
17322479
7.

Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans.

Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH.

Clin Endocrinol (Oxf). 2004 Jul;61(1):75-80.

PMID:
15212647
8.

Adiponectin in a native Canadian population experiencing rapid epidemiological transition.

Hanley AJ, Connelly PW, Harris SB, Zinman B.

Diabetes Care. 2003 Dec;26(12):3219-25.

PMID:
14633805
9.

Impact of adiponectin and ghrelin on incident glucose intolerance and on weight change.

Bennett NR, Boyne MS, Cooper RS, Royal-Thomas TY, Bennett FI, Luke A, Wilks RJ, Forrester TE.

Clin Endocrinol (Oxf). 2009 Mar;70(3):408-14. doi: 10.1111/j.1365-2265.2008.03344.x. Epub 2008 Jul 7.

PMID:
18624998
10.

Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius.

Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG.

Diabetes Care. 2000 Sep;23(9):1242-8.

12.

Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program.

Rodriguez BL, Curb JD, Burchfiel CM, Huang B, Sharp DS, Lu GY, Fujimoto W, Yano K.

Diabetes Care. 1996 Jun;19(6):587-90.

PMID:
8725856
13.

Predictive risk factors for deterioration from normoglycemic state to type 2 diabetes mellitus or impaired glucose tolerance in a Tunisian urban population.

Chihaoui M, Kanoun F, Ben Rehaiem B, Ben Brahim S, Ftouhi B, Mekaouar A, Fekih M, Mbazâd A, Zouari B, Ben Khalifa F.

Diabetes Metab. 2001 Sep;27(4 Pt 1):487-95.

PMID:
11547223
14.

Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study.

Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Kostense PJ, Yudkin JS, Heine RJ, Nijpels G, Seidell JC.

Am J Clin Nutr. 2003 May;77(5):1192-7.

15.

Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women.

Kim CH, Kim HK, Bae SJ, Park JY, Lee KU.

Metabolism. 2011 Mar;60(3):414-20. doi: 10.1016/j.metabol.2010.03.007. Epub 2010 Apr 27.

PMID:
20423745
16.

Association of leisure time physical activity and abdominal obesity with fasting serum insulin and 2-h postchallenge plasma glucose levels.

Borodulin K, Tuomilehto J, Peltonen M, Lakka TA, Sundvall J, Jousilahti P.

Diabet Med. 2006 Sep;23(9):1025-8.

PMID:
16922711
17.

Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation.

Hu G, Lindström J, Valle TT, Eriksson JG, Jousilahti P, Silventoinen K, Qiao Q, Tuomilehto J.

Arch Intern Med. 2004 Apr 26;164(8):892-6.

PMID:
15111376
18.

Lifestyle intervention and adipokine levels in subjects at high risk for type 2 diabetes: the Study on Lifestyle intervention and Impaired glucose tolerance Maastricht (SLIM).

Corpeleijn E, Feskens EJ, Jansen EH, Mensink M, Saris WH, Blaak EE.

Diabetes Care. 2007 Dec;30(12):3125-7. Epub 2007 Sep 21.

PMID:
17890316
19.

Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study.

Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T; Funagata study..

Diabetes Care. 2003 Jul;26(7):2015-20.

PMID:
12832305
20.

Supplemental Content

Support Center